cinnabarinic acid has been researched along with myelin basic protein in 1 studies
| Studies (cinnabarinic acid) | Trials (cinnabarinic acid) | Recent Studies (post-2010) (cinnabarinic acid) | Studies (myelin basic protein) | Trials (myelin basic protein) | Recent Studies (post-2010) (myelin basic protein) |
|---|---|---|---|---|---|
| 36 | 0 | 19 | 7,478 | 78 | 1,278 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allegrucci, M; Belladonna, ML; Bessede, A; Busceti, C; Fallarino, F; Fazio, F; Gargaro, M; Lionetto, L; Nicoletti, F; Notartomaso, S; Scarselli, P; Simmaco, M; Vacca, C; Volpi, C; Zappulla, C | 1 |
1 other study(ies) available for cinnabarinic acid and myelin basic protein
| Article | Year |
|---|---|
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.
Topics: Animals; Benzopyrans; Central Nervous System; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Agonists; Male; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Myelin-Oligodendrocyte Glycoprotein; Myosin Type II; Nuclear Receptor Subfamily 1, Group F, Member 3; Oxazines; Peptide Fragments; Receptors, Metabotropic Glutamate; T-Box Domain Proteins; Th17 Cells; Time Factors; Transcription Factors | 2014 |